Patients who have undergone either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) are at high risk for mortality in the event of a COVID-19 diagnosis.
Researchers assessed the efficacy of the COVID-19 convalescent plasma in offering survival benefit at 7 and 14 days for patients hospitalized with the disease.
ACS Cancer Action Network’s Survivor Views panel reveals willingness and concerns of survivors and patients regarding cancer clinical trial participation during the pandemic.
A team of investigators sought to assess the association between consumptive coagulopathy, as reflected by a prolonged prothrombin time, and host response aberrations in patients admitted to the intensive care unit with sepsis.
Review highlights current approaches to risk stratification, differential diagnosis, and the optimal use of current treatment options for polycythemia vera.
Patients who have undergone either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) are at high risk for mortality in the event of a COVID-19 diagnosis.
A systematic review of studies focused on strategies to improve patient comfort and compliance with radiotherapy treatment plans, finding that aromatherapy strategies show promise in this setting.
A letter to the editor drew attention to the increased risk of thrombotic disorder for patients with severe COVID-19, which seems to occur by interacting with the von Willebrand Factor-ADAMTS13 axis.
As the COVID-19 pandemic continues, its toll has extended beyond physical and into the emotional realm. A recent study in JAMA Network Open suggested that the prevalence of depression symptoms in the United States was more than 3 times as great during the presence of COVID-19 as it was prior to the pandemic.¹ Americans are…
Patients who speak Spanish primarily or exclusively have a unique set of struggles and barriers when getting medical care, whether as a patient or caregiver. A language barrier can be stressful and burdensome for parents trying to get help for their child. What can be done about this? A recent study from Academic Pediatrics examined…
A team of investigators sought to determine the ability of abatacept to decrease the risk of severe acute graft-vs-host disease in patients undergoing unrelated donor allogeneic hematopoietic cell transplant.
The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.
The revision is based on new clinical trial data that showed no evidence of low titer convalescent plasma being effective in the treatment of hospitalized COVID-19 patients.
This study sought to identify trends in industry payments to medical oncologists between 2014 and 2019 to determine if the Open Payments program, which has published data on industry-physician financial interactions since 2013, was associated with changes in the frequency or value of payments.
A multicenter, prospective cohort study was conducted to compare mortality and complication rates associated with cancer surgery between low-income, middle-income, and high-income countries.
A team of investigators sought to determine the effect of intermediate-dose anticoagulation and aspirin on mortality in patients hospitalized with COVID-19.
New data are reported from an ongoing, prospective, nonrandomized phase 1/2 study of eltrombopag added to immunosuppressive therapy for patients with treatment-naive severe aplastic anemia.
A team of investigators conducted a cross-sectional analysis to assess the effect of a geriatric assessment tool on older patients with hematologic malignancies.
Investigators compared elotuzumab plus lenalidomide, bortezomib, and dexamethasone (RVd) with RVd alone in the induction and maintenance therapy settings.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
The Office for Civil Rights in the US Department of Health and Human Services announced proposed changes to strengthen patients’ rights to access their own health information, improve care coordination, and reduce regulatory burdens.
Investigators aimed to determine whether the sickle cell trait was associated with myocardial infarction or coronary heart disease among African American individuals.
The National Comprehensive Cancer Network’s updated Clinical Practice Guidelines in Oncology for multiple myeloma newly include 3 new selinexor-containing regimens.
A team of investigators conducted a systematic literature review and meta-analysis to determine the effectiveness of combined calcium channel blocker and chelation therapy for reducing iron overload in patients with thalassemia.
Chemotherapy agents such as vincristine sulfate injection, vinblastine sulfate injection, and vinorelbine tartrate injection should only be prepared in IV infusion bags.
A survey of patients with cancer treated in radiation clinics of a major New York metropolitan cancer center reported satisfaction with telemedicine care, compared with in-person visits.
The FDA is alerting clinical laboratory staff and health care providers regarding the risk of false negative results with any SARS-CoV-2 test if a mutation occurs in the part of the virus’ genome assessed by that test.
Investigators discussed their clinical approaches to the diagnosis and management of malignant infantile osteopetrosis, as well as the management of long-term posttrasnplant complications.
Experts assessed mortality rates linked to allogeneic stem cell transplantation in the past 40 years using data from the European Society for Blood and Marrow Transplantation registry.
Social shifts related to the COVID-19 pandemic may be uniquely consequential for health behaviors and decisions integral to effective cancer prevention and control.
Investigators aimed to understand how well adolescents with cancer understand their prognosis compared with their health care providers and caregivers.
Patients with cancer, especially those of the African American population, who have COVID-19 infection are at a greater risk of hospitalization and death.
To accommodate patients remotely during the COVID-19 pandemic, practices may have expanded personnel access to protected health information and relied on devices that might be vulnerable to cyber attacks.
Retrospective analysis demonstrates the value in distinguishing between these conditions to salvage chemotherapy and/or targeted therapy dose in patients with cancer.